Black Rock Inc. Editas Medicine, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,832,781 shares of EDIT stock, worth $36.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,832,781

Previous 7,838,969 0.08%

Holding current value

$36.6 Million

Previous $79.4 Million 26.81%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$7.03 - $11.07 $43,501 - $68,501	-6,188 Reduced 0.08%	7,832,781 $58.1 Million
Q4 2023 Feb 13, 2024	SELL	$6.25 - $11.11 $2.01 Million - $3.57 Million	-321,064 Reduced 3.93%	7,838,969 $79.4 Million
Q3 2023 Nov 13, 2023	BUY	$6.92 - $9.31 $3.91 Million - $5.25 Million	564,337 Added 7.43%	8,160,033 $63.6 Million
Q2 2023 Aug 11, 2023	BUY	$6.36 - $11.47 $1.13 Million - $2.03 Million	177,334 Added 2.39%	7,595,696 $62.5 Million
Q1 2023 May 12, 2023	BUY	$7.03 - $11.53 $559,728 - $918,018	79,620 Added 1.08%	7,418,362 $53.8 Million

Q4 2022 Feb 13, 2023	BUY	$8.32 - $13.21 $2.96 Million - $4.7 Million	355,967 Added 5.1%	7,338,742 $65.1 Million
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $3.14 Million - $5.02 Million	258,565 Added 3.85%	6,982,775 $85.5 Million
Q2 2022 Aug 12, 2022	BUY	$9.99 - $21.35 $4.48 Million - $9.58 Million	448,940 Added 7.15%	6,724,210 $79.5 Million
Q1 2022 May 12, 2022	BUY	$14.08 - $27.63 $11.9 Million - $23.3 Million	841,894 Added 15.49%	6,275,270 $119 Million
Q4 2021 Feb 10, 2022	SELL	$26.55 - $40.57 $282,332 - $431,421	-10,634 Reduced 0.2%	5,433,376 $144 Million
Q3 2021 Nov 09, 2021	SELL	$39.27 - $72.94 $5.54 Million - $10.3 Million	-141,179 Reduced 2.53%	5,444,010 $224 Million
Q2 2021 Aug 11, 2021	BUY	$31.29 - $56.64 $175 Million - $316 Million	5,585,189 New	5,585,189 $316 Million

Others Institutions Holding EDIT

# of Institutions

243

Shares Held

69.3M

Call Options Held

564K

Put Options Held

428K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $321M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account